APT Medical Inc. (SHA:688617)
China · Delayed Price · Currency is CNY 191.64
-4.76 (-2.42%)
Jun 18, 2026, 3:00 PM CST
APT Medical Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, APT Medical stock has a consensus rating of "Strong Buy" and an average price target of ¥335.39. The average 1-year stock price forecast is 75.01% higher than the current stock price, while the lowest is ¥317.68 (+65.77%) and the highest is ¥355.00 (+85.24%).
Price Target: ¥335.39 (+75.01%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for APT Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 9 | 9 |
Financial Forecast
Revenue This Year
3.24B
from 2.58B
Increased by 25.33%
Revenue Next Year
4.12B
from 3.24B
Increased by 27.19%
EPS This Year
6.92
from 5.59
Increased by 23.79%
EPS Next Year
9.03
from 6.92
Increased by 30.47%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.3B | ||
| Avg | 3.2B | ||
| Low | 3.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 26.9% | ||
| Avg | 25.3% | ||
| Low | 23.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.92 | ||
| Avg | 6.92 | ||
| Low | 6.92 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 23.8% | ||
| Avg | 23.8% | ||
| Low | 23.8% |